This is the text extract for October Tender Results, browse documents here.

---

30 October 2009

TENDER RESULTS

The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products listed in the Invitation to Tender dated 21 December 2007 and the Invitation to Tender dated 23 December 2008. Some of the pharmaceuticals that will be delisted when the period of sole supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts until such time as the pharmaceuticals are delisted and PHARMAC will continue to subsidise their pharmaceuticals accordingly. Product Notification Forms Please note that for all changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H) suppliers are required to notify PHARMAC and the Guild by 4pm 12th November 2009. More information and product notification forms can be downloaded from our website – www.pharmac.govt.nz/schedule.asp. Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 1. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing for tender winning brand at the tender subsidy will occur on 1 December 2009, reference pricing of nontender winning brand will occur on 1 February 2010 and Sole Subsidised Supply commences on 1 May 2010.

The decisions were as follows:

Chemical Name Amoxycillin Calcitriol Calcitriol Permethrin

Presentation; Pack size and type Grans for oral liq 250 mg per 5 ml; 100 ml, bottle Cap 0.25 mcg; 30 tablets, bottle Cap 0.5 mcg; 30 tablets, bottle Lotn 5%; 30 ml OP, bottle

Current subsidy $1.27 $13.45 (per 100) $24.95 (per 100) $4.20

New tender subsidy $1.10 $3.03 $5.62 $3.65

Sole supply brand (Supplier) Ospamox (Sandoz) Airflow (Airflow) Airflow (Airflow) A-Scabies (AFT)

Brands affected by reference pricing and delisting Ranbaxy Amoxicillin (Apotex) Calcitriol-AFT Calcitriol-AFT Lyderm* (API Consumer)

* Note: Permethrin cream and lotion were tendered as one line item.

2. Tenders awarded to unlisted pharmaceuticals – listing will occur on 1 December 2009 and Sole Subsidised Supply commences on 1 March 2010.

Chemical Name Cephalexin monohydrate Cephalexin monohydrate Presentation; Pack size and type Liq 125 mg per 5 ml; 100 ml, bottle Liq 250 mg per 5 ml; 100 ml, bottle New subsidy $8.50 $11.50 Sole supply brand (Supplier) Cefalexin Sandoz (Sandoz) Cefalexin Sandoz (Sandoz)

A303157 - qA12214

---

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 3. Tenders awarded to listed pharmaceuticals where an alternative brand is already listed – listing for hospital tender winning brands of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 December 2009; DV Limits and DV pharmaceuticals will apply from 1 February 2010; de-listing of other brands in Section H will occur on 1 February 2010.

Presentation; Pack size and type Grans for oral liq 250 mg per 5 ml; 100 ml, bottle Cap 0.25 mcg; 30 tablets, bottle Cap 0.5 mcg; 30 tablets, bottle Inj 20 mg; 1 injection, vial Hospital Supply Brand (Supplier) Ospamox (Sandoz) Airflow (Airflow) Airflow (Airflow) Docetaxel Ebewe (InterPharma) Docetaxel Ebewe (InterPharma) A-Scabies (AFT) Pack Price $1.10 $3.03 $5.62 $325.00 DV Limit 1% 1% 1% 1% DV Pharmaceuticals Brand Name (Supplier) Ranbaxy Amoxicillin (Apotex) Calcitriol-AFT (AFT) Calcitriol-AFT (AFT) Docetaxel Winthrop (Sanofi-Aventis) Taxotere (Sanofi-Aventis) Docetaxel Winthrop (Sanofi-Aventis) Taxotere (Sanofi-Aventis) Lyderm* (API Consumer)

Chemical Name Amoxycillin Calcitriol Calcitriol Docetaxel **

Docetaxel ** Permethrin

Inj 80 mg; 1 injection, vial Lotn 5%; 30 ml OP, bottle

$1,300.00 $3.65

1% 1%

* Note: Permethrin cream and lotion were tendered as one line item. **Note: Docetaxel-Ebewe will also be listed in Section B of the Pharmaceutical Schedule for PCT and ECP preparations accordingly.

For the remaining products on the Invitation to Tender dated 21 December 2007 and the Invitation to Tender dated 23 December 2008 where no announcement has been made, either a decision is still pending, or is provisional and subject to the product gaining market approval and having sufficient stock. We will keep you informed regarding any changes for the remaining tender products as further decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.

A303157 - qA12214

Page 2 of 2